With FDA approval for Jaypirca, Eli Lilly introduces new BTK blood cancer drug aliu Fri, 01/27/2023 – 15:29 More: With FDA approval for Jaypirca, Eli Lilly introduces new BTK blood cancer drug Source: fierce
read moreJ&J, Legend’s Carvykti hits goal in earlier myeloma, escalates CAR-T showdown with Bristol Myers’ Abecma aliu Fri, 01/27/2023 – 11:02 More: J&J, Legend's Carvykti hits goal in earlier myeloma, escalates CAR-T showdown with Bristol Myers' Abecma Source: fierce
read moreFDA advisors vote to standardize COVID vaccines as bivalent, stump for more data kdunleavy Fri, 01/27/2023 – 10:01 More: FDA advisors vote to standardize COVID vaccines as bivalent, stump for more data Source: fierce
read moreThe last to fall: FDA nixes emergency nod on AstraZeneca’s COVID-19 antibody Evusheld fkansteiner Fri, 01/27/2023 – 09:38 More: The last to fall: FDA nixes emergency nod on AstraZeneca's COVID-19 antibody Evusheld Source: fierce
read moreMerck’s Keytruda reaches coveted postsurgery lung cancer use with broader FDA nod than Tecentriq aliu Fri, 01/27/2023 – 09:25 More: Merck’s Keytruda reaches coveted postsurgery lung cancer use with broader FDA nod than Tecentriq Source: fierce
read moreClinical study is researching patients with diabetes and advanced chronic kidney disease More: Orbsen announces results from Nephstrom trial Source: News
read more© 1994 - 2023 B.M. Pharmaceuticals